These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 16517706)

  • 1. Alloantigen affinity and CD4 help determine severity of graft-versus-host disease mediated by CD8 donor T cells.
    Yu XZ; Albert MH; Anasetti C
    J Immunol; 2006 Mar; 176(6):3383-90. PubMed ID: 16517706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The balance between donor T cell anergy and suppression versus lethal graft-versus-host disease is determined by host conditioning.
    Gonzalez M; Quezada SA; Blazar BR; Panoskaltsis-Mortari A; Rudensky AY; Noelle RJ
    J Immunol; 2002 Nov; 169(10):5581-9. PubMed ID: 12421935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro-established alloantigen-specific CD8+ CTLs mediate graft-versus-tumor activity in the absence of graft-versus-host disease.
    Hartmann N; Leithäuser F; Albers C; Duyster J; Möller P; Debatin KM; Strauss G
    Leukemia; 2011 May; 25(5):848-55. PubMed ID: 21331071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of stem cell transcriptional programs normally expressed in embryonic and neural stem cells in alloreactive CD8+ T cells mediating graft-versus-host disease.
    Kato K; Cui S; Kuick R; Mineishi S; Hexner E; Ferrara JL; Emerson SG; Zhang Y
    Biol Blood Marrow Transplant; 2010 Jun; 16(6):751-71. PubMed ID: 20116439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The fate of donor T-cell receptor transgenic T cells with known host antigen specificity in a graft-versus-host disease model.
    Dey B; Yang YG; Preffer F; Shimizu A; Swenson K; Dombkowski D; Sykes M
    Transplantation; 1999 Jul; 68(1):141-9. PubMed ID: 10428282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opposing effects of ICOS on graft-versus-host disease mediated by CD4 and CD8 T cells.
    Yu XZ; Liang Y; Nurieva RI; Guo F; Anasetti C; Dong C
    J Immunol; 2006 Jun; 176(12):7394-401. PubMed ID: 16751384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting of inducible costimulator (ICOS) expressed on alloreactive T cells down-regulates graft-versus-host disease (GVHD) and facilitates engraftment of allogeneic bone marrow (BM).
    Taylor PA; Panoskaltsis-Mortari A; Freeman GJ; Sharpe AH; Noelle RJ; Rudensky AY; Mak TW; Serody JS; Blazar BR
    Blood; 2005 Apr; 105(8):3372-80. PubMed ID: 15618467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cell-specific notch inhibition blocks graft-versus-host disease by inducing a hyporesponsive program in alloreactive CD4+ and CD8+ T cells.
    Sandy AR; Chung J; Toubai T; Shan GT; Tran IT; Friedman A; Blackwell TS; Reddy P; King PD; Maillard I
    J Immunol; 2013 Jun; 190(11):5818-28. PubMed ID: 23636056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion of alloantigen-reactive thymocytes as a mechanism of adult tolerance induction following intrathymic antigen administration.
    Jones ND; Fluck NC; Roelen DL; Mellor AL; Morris PJ; Wood KJ
    Eur J Immunol; 1997 Jul; 27(7):1591-600. PubMed ID: 9247566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lethal murine graft-versus-host disease induced by donor gamma/delta expressing T cells with specificity for host nonclassical major histocompatibility complex class Ib antigens.
    Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Barrett TA; Bluestone JA; Vallera DA
    Blood; 1996 Jan; 87(2):827-37. PubMed ID: 8555509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcineurin inhibition rescues alloantigen-specific central memory T cell subsets that promote chronic GVHD.
    Wang Y; Ullah MA; Waltner OG; Bhise SS; Ensbey KS; Schmidt CR; Legg SR; Sekiguchi T; Nelson EL; Kuns RD; Nemychenkov NS; Atilla E; Yeh AC; Takahashi S; Boiko JR; Varelias A; Blazar BR; Koyama M; Minnie SA; Clouston AD; Furlan SN; Zhang P; Hill GR
    J Clin Invest; 2024 Jun; 134(11):. PubMed ID: 38828727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD103 deficiency prevents graft-versus-host disease but spares graft-versus-tumor effects mediated by alloreactive CD8 T cells.
    Liu K; Anthony BA; Yearsly MM; Hamadani M; Gaughan A; Wang JJ; Devine SM; Hadley GA
    PLoS One; 2011; 6(7):e21968. PubMed ID: 21779359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific donor Vbeta-associated CD4 T-cell responses correlate with severe acute graft-versus-host disease directed to multiple minor histocompatibility antigens.
    Jones SC; Friedman TM; Murphy GF; Korngold R
    Biol Blood Marrow Transplant; 2004 Feb; 10(2):91-105. PubMed ID: 14750075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Graft-vs.-host and graft-vs.-leukemia reactions after delayed infusions of donor T-subsets.
    Johnson BD; Becker EE; Truitt RL
    Biol Blood Marrow Transplant; 1999; 5(3):123-32. PubMed ID: 10392958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease.
    Drobyski WR; Majewski D; Hanson G
    Biol Blood Marrow Transplant; 1999; 5(4):222-30. PubMed ID: 10465102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alloantigen recognition is critical for CD8 T cell-mediated graft anti-tumor activity against murine BCL1 lymphoma after myeloablative bone marrow transplantation.
    Pillai A; Teo P; George T; Mukhopadhyay A; Dejbakhsh-Jones S; Strober S
    Bone Marrow Transplant; 2007 Sep; 40(5):487-97. PubMed ID: 17603512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of B7RP-1/ICOS co-stimulation to lethal acute GVHD.
    Fujimura J; Takeda K; Kaduka Y; Saito M; Akiba H; Yagita H; Yamashiro Y; Shimizu T; Okumura K
    Pediatr Transplant; 2010 Jun; 14(4):540-8. PubMed ID: 20136724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo maturation of allo-specific CD8 CTL and prevention of lupus-like graft-versus-host disease is critically dependent on T cell signaling through the TNF p75 receptor but not the TNF p55 receptor.
    Soloviova K; Puliaiev M; Haas M; Via CS
    J Immunol; 2013 May; 190(9):4562-72. PubMed ID: 23526821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alloreactive CD4 T cell activation in vivo: an autonomous function of the indirect pathway of alloantigen presentation.
    Reed AJ; Noorchashm H; Rostami SY; Zarrabi Y; Perate AR; Jeganathan AN; Caton AJ; Naji A
    J Immunol; 2003 Dec; 171(12):6502-9. PubMed ID: 14662850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of IL-10 by alloreactive sibling donor cells and its influence on the development of acute GVHD.
    Weston LE; Geczy AF; Briscoe H
    Bone Marrow Transplant; 2006 Jan; 37(2):207-12. PubMed ID: 16284610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.